---
title: "Element Avanti"
ocid: "ocds-r6ebe6-0000789217"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000789217"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000789217.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000789217.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "UNIVERSITY OF EDINBURGH"
published: "2025-01-30"
---

# Element Avanti

Buyer: UNIVERSITY OF EDINBURGH  
Current stage: Award  
OCID: ocds-r6ebe6-0000789217

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000789217)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000789217.json)

## Summary

The University of Edinburgh has completed a procurement process for the acquisition of the Element AVITI sequencing platform, under the title "Element Avanti". This procurement falls within the education sector and specifically aims to enhance the University's capabilities in near-to-clinic genomics research. The equipment will be located at the University of Edinburgh, with the purchasing organisation situated at Charles Stewart House, Edinburgh. The process was conducted under a limited procurement method, resulting in an award without prior publication of a call for competition due to the unique technical requirements of the equipment. The contract was awarded on 17 January 2025, highlighting the process's timely completion.

This tender represents a significant opportunity for businesses involved in advanced genomic technologies, particularly those focusing on sequencing and biobank integrations. Suppliers providing state-of-the-art genomic sequencing platforms and related technologies would find this procurement to be highly relevant. Companies capable of offering innovative solutions in genomics with a focus on high-quality data and throughput will benefit, as these are the core requirements outlined by the University of Edinburgh. The award to Elemental underscores the demand for specialised equipment that can support cutting-edge research, thereby presenting growth opportunities for businesses that can meet such high technical standards.

## Notice

This purchase builds on the University and its Genetics Core expertise in near-to-clinic genomics, current experience of working with technology, our hosted biobank and already in place embedded genomic automation. The implementation of the equipment will significantly impact ongoing and future research projects. For example, it will facilitate the investigation of genomic variation in funded, and future, projects of structurally-diverse tumour types of unmet need. The Genetics Core requires a short-read sequencing platform that has the ability to sequence low-diversity libraries without the need to add in large amounts of PhiX (more than 5%) to artificially introduce base diversity. It needs to be able to work with single cell platforms, especially 10x Genomics and Parse, and be able to run any combination of their barcodes for these experiments. It needs to have the ability to work with low to medium sample numbers (two to twelve) while maintaining high quality data and throughput. The chosen system in the Element AVITI is the only system on the market that can fulfil this requirement.

### Lot Information

Lot 1

This purchase builds on the University and its Genetics Core expertise in near-to-clinic genomics, current experience of working with technology, our hosted biobank and already in place embedded genomic automation. The implementation of the equipment will significantly impact ongoing and future research projects. For example, it will facilitate the investigation of genomic variation in funded, and future, projects of structurally-diverse tumour types of unmet need. The Genetics Core requires a short-read sequencing platform that has the ability to sequence low-diversity libraries without the need to add in large amounts of PhiX (more than 5%) to artificially introduce base diversity. It needs to be able to work with single cell platforms, especially 10x Genomics and Parse, and be able to run any combination of their barcodes for these experiments. It needs to have the ability to work with low to medium sample numbers (two to twelve) while maintaining high quality data and throughput. The chosen system in the Element AVITI is the only system on the market that can fulfil this requirement.

### Procurement Information

This purchase builds on the University and its Genetics Core expertise in near-to-clinic genomics, current experience of working with technology, our hosted biobank and already in place embedded genomic automation. The implementation of the equipment will significantly impact ongoing and future research projects. For example, it will facilitate the investigation of genomic variation in funded, and future, projects of structurally-diverse tumour types of unmet need. The Genetics Core requires a short-read sequencing platform that has the ability to sequence low-diversity libraries without the need to add in large amounts of PhiX (more than 5%) to artificially introduce base diversity. It needs to be able to work with single cell platforms, especially 10x Genomics and Parse, and be able to run any combination of their barcodes for these experiments. It needs to have the ability to work with low to medium sample numbers (two to twelve) while maintaining high quality data and throughput. The chosen system in the Element AVITI is the only system on the market that can fulfil this requirement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN522830 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 30 Jan 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 17 Jan 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £290,640 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | UNIVERSITY OF EDINBURGH |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH1 1HT |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | City Centre |
| Westminster constituency | Edinburgh East and Musselburgh |
| Delivery location | TLM75 City of Edinburgh |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ELEMENTAL |

## CPV Codes

### Divisions

- 42 - Industrial machinery

### Codes

- 42931100 - Laboratory centrifuges and accessories

## Release History

- 30 Jan 2025 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN522830

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN522830
  Element Avanti - This purchase builds on the University and its Genetics Core expertise in near-to-clinic genomics, current experience of working with technology, our hosted biobank and already in place embedded genomic automation. The implementation of the equipment will significantly impact ongoing and future research projects. For example, it will facilitate the investigation of genomic variation in funded, and future, projects of structurally-diverse tumour types of unmet need. The Genetics Core requires a short-read sequencing platform that has the ability to sequence low-diversity libraries without the need to add in large amounts of PhiX (more than 5%) to artificially introduce base diversity. It needs to be able to work with single cell platforms, especially 10x Genomics and Parse, and be able to run any combination of their barcodes for these experiments. It needs to have the ability to work with low to medium sample numbers (two to twelve) while maintaining high quality data and throughput. The chosen system in the Element AVITI is the only system on the market that can fulfil this requirement.

## Notice URLs

- http://
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000789217
- https://www.ed.ac.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000789217. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000789217.json.